ST新海(002089.SZ):前三季業績預虧4200萬元-5200萬元
格隆匯 10 月 15日丨ST新海(002089.SZ)披露2020年前三季度業績預告,2020年前三季度業績預計虧損4200萬元-5200萬元,比上年同期增長90.56%-92.37%,基本每股收益虧損0.0306元/股——0.0378元/股。2020年第三季度預計虧損4247.68萬元-5247.68萬元,比上年同期增長87.77%-90.10%,基本每股收益虧損0.0309元/股——0.0382元/股。
業績變動原因:1、新海宜集團對通家集團擔保,產生的預計負債,金額約為1600萬元,屬於非經常性損益。2、賬齡變化,計提的資產減值準備。3、重要子公司新納晶停產,需承擔折舊等固定性費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.